logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8883724 B1

PDFFull Text
Date of Patent:
Nov. 11, 2014

Filed:

Nov. 04, 2009

Active antiangiogenic therapy

Applicants:

Mónica Bequet Romero, Ciudad de la Habana, CU;

Boris Ernesto Acevedo Castro, Ciudad de la Habana, CU;

Jorge Victor Gavilondo Cowley, Ciudad de la Habana, CU;

Luis Enrique Fernández Molina, Ciudad de la Habana, CU;

Omar Lopez Ocejo, Ciudad de la Habana, CU;

Ricardo DE LA Caridad Silva Rodriguez, Ciudad de la Habana, CU;

Alexis Musachio Lasa, Mariel, CU;

Ernesto Galban Rodriguez, Ciudad de la Habana, CU;

Dania Marcia Vásquez Blomquist, Ciudad de la Habana, CU;

Inventors:

Mónica Bequet Romero, Ciudad de la Habana, CU;

Boris Ernesto Acevedo Castro, Ciudad de la Habana, CU;

Jorge Victor Gavilondo Cowley, Ciudad de la Habana, CU;

Luis Enrique Fernández Molina, Ciudad de la Habana, CU;

Omar Lopez Ocejo, Ciudad de la Habana, CU;

Ricardo de la Caridad Silva Rodriguez, Ciudad de la Habana, CU;

Alexis Musachio Lasa, Mariel, CU;

Ernesto Galban Rodriguez, Ciudad de la Habana, CU;

Dania Marcia Vásquez Blomquist, Ciudad de la Habana, CU;

Assignee:

Centro de Ingenieria Genética y Biotecnologia, Ciudad de la Habana, CU;

Attorney:

Hoffmann & Baron, LLP

Primary Examiner:

Ja'Na Hines

Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 39/395 (2006.01); C07K 14/475 (2006.01); C07K 16/00 (2006.01); C07K 14/515 (2006.01); C07K 14/52 (2006.01); A61K 48/00 (2006.01); C07K 14/71 (2006.01); C07K 14/715 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/715 (2013.01); A61K 2039/55594 (2013.01); A61K 38/1858 (2013.01); A61K 39/001 (2013.01); A61K 2039/5256 (2013.01); C07K 14/515 (2013.01); A61K 38/1866 (2013.01); C07K 14/52 (2013.01); A61K 48/005 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55516 (2013.01); C07K 14/71 (2013.01); A61K 39/0011 (2013.01); A61K 39/0005 (2013.01); A61K 2039/5258 (2013.01); A61K 39/0008 (2013.01);
Abstract

Application of oligonucleotide and polypeptide sequences of molecules of the family of the vascular permeability factor (VPF), their receptors, and co-receptors, as well as their modifications, in the active immunotherapy of pathologic entities in which course is associated to the increase of angiogenesis. These procedures can be employed in the single or combined therapy for the treatment of cancer and its metastasis, acute and chronic inflammatory processes, infectious diseases, autoimmune diseases, diabetic and newborn retinopathies, organ transplant rejection, macular degeneration, neovascular glaucoma, hemangioma, and angiofibroma, among others.

Find Patent Forward Citations

Bequet Romero, Mónica. (2014). Active antiangiogenic therapy (U.S. Patent No. 8883724). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8883724

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…